Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31063955)

  • 1. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
    Wang T; Ding Y; Yang Y; Wang Z; Gao W; Li D; Wei J; Sun Y
    Biomed Pharmacother; 2019 Jul; 115():108899. PubMed ID: 31063955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
    Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M
    Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
    Tang XY; Zhu YQ; Tao WH; Wei B; Lin XL
    Postgrad Med J; 2007 May; 83(979):338-43. PubMed ID: 17488865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.
    Lin Y; Peng N; Li J; Zhuang H; Hua ZC
    Mol Cancer; 2013 Jun; 12():54. PubMed ID: 23758884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.
    Dai H; Jiang Y; Luo Y; Bie P; Chen Z
    Phytomedicine; 2019 Sep; 62():152953. PubMed ID: 31128486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways.
    Meng G; Wang W; Chai K; Yang S; Li F; Jiang K
    Int J Oncol; 2015 Mar; 46(3):1007-17. PubMed ID: 25573072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
    Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
    Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.
    Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC
    Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1/DDP Nasopharyngeal Cancer Cells.
    Wang X; Zhang JJ; Sun YM; Zhang J; Wang LR; Li JC; Liu H
    Folia Biol (Praha); 2015; 61(5):195-202. PubMed ID: 26667576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells.
    Ho JN; Byun SS; Lee S; Oh JJ; Hong SK; Lee SE; Yeon JS
    J Urol; 2015 Mar; 193(3):1016-22. PubMed ID: 25229559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
    Liu Y; Xiao E; Yuan L; Li G
    DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.
    Jiang QW; Cheng KJ; Mei XL; Qiu JG; Zhang WJ; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Zhang X; Lv M; Chen MW; Wei X; Shi Z
    Oncotarget; 2015 Oct; 6(32):32790-804. PubMed ID: 26447544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy.
    Zheng Y; Kong F; Liu S; Liu X; Pei D; Miao X
    Drug Deliv; 2021 Dec; 28(1):2033-2043. PubMed ID: 34569906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Amplified pH/ROS Dual-Responsive Co-Delivery Nano-System with Chemo-Photodynamic Combination Therapy in Hepatic Carcinoma Treatment.
    Huang Y; Wu S; Li J; He C; Cheng Y; Li N; Wang Y; Wu Y; Zhang J
    Int J Nanomedicine; 2024; 19():3737-3751. PubMed ID: 38699684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
    Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
    Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis.
    Wang Y; Wang H; Zhang W; Shao C; Xu P; Shi CH; Shi JG; Li YM; Fu Q; Xue W; Lei YH; Gao JY; Wang JY; Gao XP; Li JQ; Yuan JL; Zhang YT
    PLoS One; 2013; 8(1):e50175. PubMed ID: 23365634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.
    Hung FM; Chen YL; Huang AC; Hsiao YP; Yang JS; Chung MT; Chueh FS; Lu HF; Chung JG
    Oncol Rep; 2013 Mar; 29(3):1053-60. PubMed ID: 23314229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling.
    Wang H; Ma D; Wang C; Zhao S; Liu C
    Med Sci Monit; 2016 May; 22():1827-36. PubMed ID: 27239780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.
    Arora N; Alsaied O; Dauer P; Majumder K; Modi S; Giri B; Dudeja V; Banerjee S; Von Hoff D; Saluja A
    PLoS One; 2017; 12(2):e0171827. PubMed ID: 28192510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.
    Shi Y; Zhao H; Ye J; Li Z; Deng M; Zha J; Zhou Y; Zeng H; Lin Y; Pu X; Guo C; Song H; Qiu Y; Xu B
    Mol Carcinog; 2020 Sep; 59(9):1076-1087. PubMed ID: 32691884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.